Imograf Forte Lotion contains Tacrolimus 0.1% w/v, a topical immunomodulator indicated for the treatment of moderate to severe atopic dermatitis in patients who have not responded adequately to conventional therapies or when those therapies are contraindicated. Tacrolimus acts by inhibiting calcineurin, thereby suppressing T-lymphocyte activation and the release of pro-inflammatory cytokines, which play a key role in the pathogenesis of inflammatory skin conditions. Imograf Forte Lotion is applied directly to affected areas, providing targeted anti-inflammatory effects without the adverse skin atrophy commonly associated with topical corticosteroids. It is particularly useful for delicate skin regions such as the face, neck, and flexural areas. The medication should be used as directed by a healthcare professional, typically twice daily, and treatment duration may vary based on clinical response. Common adverse effects include transient burning or itching at the application site, which usually diminishes with continued use. Patients should avoid exposure to sunlight and ultraviolet light during treatment. Imograf Forte Lotion is contraindicated in individuals with hypersensitivity to tacrolimus or any of its excipients. It is essential to follow medical advice regarding use in pediatric populations and during pregnancy or lactation.